{
    "code": "52026283",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52026283",
    "time": "2020-05-15 05:03:22",
    "許可證字號": "衛部藥輸字第026283號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "113\/03\/25",
    "發證日期": "103\/03\/25",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA05202628301",
    "中文品名": "維帕特 10毫克\/毫升輸液溶液",
    "英文品名": "Vimpat 10mg\/ml solution for infusion",
    "適應症": "1.四歲以上有或無次發性全身發作的局部癲癇發作病人的單一藥物治療。\r\n2.四歲以上之(1)複雜性局部癲癇發作(complex partial seizure)與 (2)單純或複雜性局部發作之合併有次發性全身發作(simple or complex partial seizure with secondary generalization)癲癇病人之輔助治療(add-on therapy)。",
    "劑型": "279注射液",
    "包裝": "200毫克小瓶裝 100小瓶以下盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "108\/03\/25",
    "主成分略述": "Lacosamide",
    "限制項目": "02輸　入",
    "申請商名稱": "620101S739  台灣優時比貿易有限公司",
    "申請商地址": "台北市松山區敦化北路88號12樓之2",
    "主製造廠": [
        {
            "製造廠名稱": "FBE0064000  UCB PHARMA SA",
            "製造廠廠址": "CHEMIN DU FORIEST, B-1420 BRAINE-L&#39;ALLEUD, BELGIUM",
            "製造廠公司地址": "",
            "製造廠國別": "BELGIUM",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "FBE0059000  UCB S.A.",
            "製造廠廠址": "ALLEE DE LA RECHERCHE, 60 B-1070 BRUSSELS, BELGIUM",
            "製造廠公司地址": "",
            "製造廠國別": "BELGIUM",
            "製程": "許可證持有者"
        },
        {
            "製造廠名稱": "FDE0550100  AESICA PHARMACEUTICALS GmbH",
            "製造廠廠址": "MITTELSTRASSE 15, D-40789 MONHEIM AM RHEIN, GERMANY",
            "製造廠公司地址": "",
            "製造廠國別": "GERMANY",
            "製程": "次包裝廠"
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2812002300",
            "成分名稱": "Lacosamide",
            "含量描述": "",
            "含量": "10.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "Vimpat_IV_中文仿單_ 兒科 20200206-109-02-26.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026283&Seq=006&Type=9"
        },
        {
            "title": "CIB72284B_4021803+LBL+VIMPAT+IV+10MG_ML+5X20ML+VIA+TW-107-05-30(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026283&Seq=004&Type=8"
        },
        {
            "title": "CIB72282B_4021802+BOX+VIMPAT+IV+10MG_ML+5X20ML+VIA+TW-107-05-30(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026283&Seq=003&Type=8"
        },
        {
            "title": "標籤_維帕特輸液溶液_藥輸026283號-103-06-18.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026283&Seq=002&Type=8"
        }
    ]
}